ECRI Institute and FDA Announce Top Speakers for Free Patient-Centeredness Conference

FDA's Margaret Hamburg, AHRQ's Carolyn Clancy, PCORI's Joe Selby, and 40 Other Leaders Address Policy, Practice, Health Law, and More

PLYMOUTH MEETING, Pa., Nov. 1, 2011 /PRNewswire-USNewswire/ -- ECRI Institute, an independent nonprofit that researches the best approaches to improving patient care, and the U.S. Food and Drug Administration (FDA) are co-sponsoring a free public conference on the evidence, programs, and implications of patient-centeredness in healthcare on November 29-30, 2011, at the FDA's White Oak Campus in Silver Spring, MD.

(Logo: http://photos.prnewswire.com/prnh/20110112/DC29081LOGO).

Patient-Centeredness in Policy and Practice: A Conference on Evidence, Programs, and Implications, ECRI Institute's 18th annual conference, features more than 40 distinguished speakers, including Margaret Hamburg, MD, Commissioner, FDA; Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality; Karen Ignagni, President and CEO, America's Health Insurance Plans; Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiological Health, FDA; Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA; and Joe V. Selby, MD, MPH, Executive Director, Patient-Centered Outcomes Research Institute.

"This conference comes at a critical moment because the elements of patient-centeredness are in play in significant ways," says Jeffrey C. Lerner, PhD, President and CEO, ECRI Institute. "FDA regulates 25 cents of every dollar consumers spend, so it makes sense to co-sponsor this wide-ranging conference with them," adds Lerner.

The term "patient-centeredness" is now enshrined in law by the Affordable Care Act, which created the new Patient-Centered Outcomes Research Institute. Patient-centeredness is increasingly embedded in program developments at the federal and state level, and in the private sector, too. But what does patient-centeredness actually mean? What programs are working and how do we know? Will patient-centeredness have staying power? Is there a business case for patient-centeredness?

"The patient is the ultimate beneficiary of innovative medical technology," said Jeffrey Shuren, MD, director of the FDA's Center for Devices and Radiological Health. "Patient experience can help FDA make better informed benefit-risk determinations."

The two-day program features eleven sessions that move progressively from theme to theme so that attendees who participate from the first through the last session will gain a coherent understanding of many of the most crucial elements in the movement towards patient centeredness. Day 1 sessions cover researching and regulating for patient-centeredness; health law; patient-centeredness as a core medical skill; the use of evidence in patient-centered informed consent; quality measurement in building accountability; and  communicating evidence-based information as well as influencing consumer perception and behavior through social media and behavioral economics.

Day 2 sessions examine the use of technology in patient reporting; FDA's perspective on the role that patients play in the life cycle of medical products; patient centeredness in health systems; federal and state models; and an important closing session on the business case for patient centeredness.

Conference speakers and moderators include:

• Annette Bar-Cohen, Executive Director, The Center for National Breast Cancer Coalition Advocacy and Training
• Christine Bechtel, Vice President, National Partnership for Women & Families
• Gregory Campbell, PhD, Director, Division of Biostatistics, U.S. Food and Drug Administration
• Carolyn M. Clancy, MD, Director, Agency for Healthcare Research and Quality; Member, Patient-Centered Outcomes Research Institute (PCORI) Governing Board
• John M. Colmers, MPH, Vice President, Health Care Transformation and Strategic Planning, Johns Hopkins Medicine
• Malcolm Cox, MD, Chief Academic Affiliations Officer, Veterans Health Administration
• Leah Hole-Curry, JD, Medical Administrator, Department of Labor and Industries, Washington State; Member, Patient-Centered Outcomes Research Institute (PCORI) Governing Board
• Susan Dentzer, Editor-in-Chief, Health Affairs
• Kay Dickersin, PhD, Director, Center for Clinical Trials, Johns Hopkins Bloomberg School of Public Health
• L. Allen Dobson, MD, President and CEO, Community Care of North Carolina
• Diane Dorman, Public Policy Vice President, National Organization for Rare Disorders
• David Dorsey, JD, Acting Deputy Commissioner for Policy, Planning and Budget, U.S. Food and Drug Administration
• Susan Edgman-Levitan, Executive Director, John D. Stoeckle Center for Primary Care Innovation, Massachusetts General Hospital, Boston
• Michael Fordis, MD, Director, Center for Collaborative and Interactive Technologies; Director, John M. Eisenberg Center for Clinical Decisions and Communications Science; and Senior Associate Dean for Continuing Medical Education, Baylor College of Medicine
• Daniel M. Fox, PhD, President Emeritus, Milbank Memorial Fund
• Robert Galvin, MD, Chief Executive Officer of Equity Healthcare, The Blackstone Group
• Margaret A. Hamburg, MD, Commissioner, U.S. Food and Drug Administration
• Eric Holmboe, MD, Chief Medical Officer, American Board of Internal Medicine
• Carmen Hooker-Odom, MRP, President, Milbank Memorial Fund
• David Hoyt, MD, FACS, Executive Director, American College of Surgeons
• Karen M. Ignagni, President and Chief Executive Officer, America's Health Insurance Plans (AHIP)
• Clarion E. Johnson, MD, Medical Director - Global, Medicine and Occupational Health, Exxon Mobil Corporation
• Richard Kuntz, MD, MSc, Senior Vice President and Chief Scientific, Clinical and Regulatory Officer, Medtronic Inc., and member, Member, Patient-Centered Outcomes Research Institute (PCORI) Governing Board
• Joel Kupersmith, MD, Chief Research and Development Officer, Veterans Health Administration
• Jeffrey C. Lerner, PhD, President and CEO, ECRI Institute
• Sharon Levine, MD, Associate Executive Director, The Permanente Medical Group, Inc.; Member, Patient-Centered Outcomes Research Institute (PCORI) Governing Board  
• John J. Lynch III, FACHE, President and Chief Executive Officer, Main Line Health
• Ben Moulton, JD, MPH, Senior Legal Advisor, The Foundation for Informed Medical Decision Making
• Michael Park, JD, Counsel, Alston and Bird
• John B. Reiss, JD, PhD, Partner, Saul Ewing, LLP
• Murray N. Ross, PhD, Vice President, Kaiser Foundation Health Plan; Director, Kaiser Permanente Institute for Health Policy
• Christopher M. Schroeder, Chief Executive Officer, HealthCentral
• Amy Schwartz, PhD, Founder, IDEO Chicago's User Research Group
• J. Sanford Schwartz, MD, Leon Hess Professor of Medicine, Health Care Management, and Economics, School of Medicine and the Wharton School, University of Pennsylvania
• Joe V. Selby, MD, MPH, Executive Director, Patient-Centered Outcomes Research Institute (PCORI)
• Karen Sepucha, PhD, Director, Health Decision Sciences Center, Massachusetts General Hospital; Assistant Professor, Harvard Medical School
• Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration
• Jane Hyatt Thorpe, JD, Program Director, College of Professional Studies at the George Washington University, and Associate Research Professor, School of Public Health and Health Services, the George Washington University
• Dale Collins Vidal, MD, Director, The Center for Informed Choice; Professor of Surgery and of Community and Family Medicine; Medical Director, Comprehensive Breast Program, Dartmouth Hospital and Medical School
• Kevin Volpp, MD, PhD, Staff Physician, Philadelphia VA Medical Center; Director, Center for Health Incentives and Behavioral Economics, Leonard Davis Institute; Director, UPHS Center for Innovations in Health Care Financing; Professor of Medicine and Health Care Management, Perelman School of Medicine and the Wharton School, University of Pennsylvania
• Mary Weick-Brady, MSN, RN, Senior Policy Analyst, Center for Devices and Radiological Health, U.S. Food and Drug Administration
• Steven E. Weinberger, MD, FACP, Executive Vice-President, Chief Executive Officer, American College of Physicians
• Janet Woodcock, MD, Director, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration

Senior leaders from the U.S. Agency for Healthcare Research and Quality, Health Affairs, Foundation for Informed Medical Decision Making, American Board of Internal Medicine, Kaiser Permanente Institute for Health Policy, the Milbank Memorial Fund, and the Leonard Davis Institute of Health Economics at the University of Pennsylvania played key roles in designing the program intended for multiple healthcare constituencies, including payers and providers, policymakers, researchers, industry, government, and consumer groups.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).  ECRI Institute is accredited by the ACCME to provide continuing medical education for physicians. ECRI Institute designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits(TM). Details on continuing legal education credits will be posted to the conference site. Credits are only applicable to the live event.

There is no fee to attend this program in person or via webcast, but space is limited and early registration is strongly recommended. ECRI Institute will offer live updates from the event on Twitter at #ECRI_FDA. 

For conference details and to register, visit www.ecri.org/2011conf. For additional information, contact ECRI Institute by e-mail at [email protected], call (610) 825-6000, ext. 5310, or write to 5200 Butler Pike, Plymouth Meeting, PA 19462.

ECRI Institute (www.ecri.org), a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes are best to enable improved patient care. As pioneers in this science for more than 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. Strict conflict-of-interest guidelines ensure objectivity. ECRI Institute is designated as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO, listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services, strives to achieve the highest levels of safety and quality in healthcare by collecting and analyzing patient safety information and sharing lessons learned and best practices. Find ECRI Institute on Facebook (www.facebook.com/ECRIInstitute) and on Twitter (www.twitter.com/ECRI_Institute).

SOURCE ECRI Institute